National Heart, Lung, And Blood Institute (nhlbi)
Clinical trials sponsored by National Heart, Lung, And Blood Institute (nhlbi), explained in plain language.
-
New hope for lung transplant patients: experimental drug aims to prevent organ rejection
Disease control Not yet recruitingThis early-stage study is testing whether fostamatinib, an oral medication, is safe for lung transplant patients who develop antibodies against their new lungs. Thirty adult participants will take either the study drug or a placebo pill for eight weeks while continuing their stan…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Apr 03, 2026 20:10 UTC
-
Heart doctors try new tool to reach hidden trouble spots
Disease control Not yet recruitingThis study is testing a new heart procedure called VINTAGE for people with dangerous irregular heartbeats that haven't responded to standard treatments. Doctors will use special catheters to navigate inside the heart muscle walls to reach areas that are normally hard to access. T…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Super-Computer aims to sharpen heart scans
Diagnosis Not yet recruitingThis study is testing a new computer method to create sharper, more detailed pictures from standard heart CT scans. It involves 1,000 adults who already need a heart CT for their medical care. Researchers will compare the standard scan images to new, super high-resolution version…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC